Clinical Medicine VI. (Poster discussion will take place on the terrace of the room during the Coffee Break)
Szabó, István Viktor
Semmelweis University Medical Imaging Centre
+36202839347
istvan.szabo97@gmail.com
The Predictive Role of Artificial Intelligence-Based Chest CT Quantification in Patients with COVID-19 Pneumonia
István Viktor Szabó 1, Judit Simon 1,2, Chiara Nardocci 1, Anna Sára Kardos 1,2, Norbert Nagy 1, Renad-Heyam Abdelrahman 1, Emese Zsarnóczay 1,2, Bence Fejér 1, Balázs Futácsi 1, Veronika Müller 3, Béla Merkely 2, Pál Maurovich-Horvat 1,2
1 Medical Imaging Centre, Semmelweis University
2 MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University
3 Department of Pulmonology, Semmelweis University
Szóbeli
Clinical Medicine VI. (Poster discussion will take place on the terrace of the room during the Coffee Break)
English
Clinical Medicine
Introduction: The use of artificial intelligence is rising in radiology by the day. One of the main prerequisites of a well-functioning AI is a great database of medical data, which was given during the COVID-19 pandemic.
Aims: We sought to analyze the prognostic value of laboratory and clinical data, and an artificial intelligence (AI)-based algorithm for Coronavirus disease 2019 (COVID-19) severity scoring, on CT-scans of patients hospitalized with COVID-19. Moreover, we aimed to determine personalized probabilities of clinical deterioration.
Methods: Data of symptomatic patients with COVID-19 who underwent chest-CT-examination at the time of hospital admission between April and November 2020 were analyzed. COVID-19 severity score was automatically quantified for each pulmonary lobe as the percentage of affected lung parenchyma with the AI-based algorithm. Clinical deterioration was defined as a composite of admission to the intensive care unit, need for invasive mechanical ventilation, use of vasopressors or in-hospital mortality.
Results: In total 326 consecutive patients were included in the analysis (mean age 66.7 ± 15.3 years, 52.1% male) of whom 85 (26.1%) experienced clinical deterioration. In the multivariable regression analysis prior myocardial infarction (OR = 2.81, 95% CI = 1.12-7.04, p = 0.027), immunodeficiency (OR = 2.08, 95% CI = 1.02-4.25, p = 0.043), C-reactive protein (OR = 1.73, 95% CI = 1.32-2.33, p < 0.001) and AI-based COVID-19 severity score (OR = 1.08; 95% CI = 1.02-1.15, p = 0.013) appeared to be independent predictors of clinical deterioration. Personalized probability values were determined.
Conclusion: AI-based COVID-19 severity score assessed at hospital admission can provide additional information about the prognosis of COVID-19, possibly serving as a useful tool for individualized risk-stratification.
Funding: This research was funded by the Thematic Excellence Programme (2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University, grant number 2020-4.1.1.-TKP2020.
Semmelweis University, Doctoral School of Theoretical and Translational Medicine
Dr. Maurovich-Horvat Pál
I give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
szóbeli
nem rendelkezett róla
5715
10:15
10:30
István Viktor Szabó 1, Judit Simon 1,2, Chiara Nardocci 1, Anna Sára Kardos 1,2, Norbert Nagy 1, Renad-Heyam Abdelrahman 1, Emese Zsarnóczay 1,2, Bence Fejér 1, Balázs Futácsi 1, Veronika Müller 3, Béla Merkely 2, Pál Maurovich-Horvat 1,2
1 Medical Imaging Centre, Semmelweis University
2 MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University
3 Department of Pulmonology, Semmelweis University